CETP and LCAT Gene Polymorphisms Are Associated with High-Density Lipoprotein Subclasses and Acute Coronary Syndrome

Gilberto Vargas-Alarcon1,2, Oscar Perez-Mendez1,2, Gabriel Herrera-Maya1

  • 1Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, 14080, Mexico City, Mexico.

Lipids
|March 24, 2018
PubMed

Insights

Genetic variations in CETP (rs708272) and LCAT (rs2292318) are linked to acute coronary syndrome (ACS) risk and altered high-density lipoprotein cholesterol (HDL-C) levels and subclasses. These findings highlight genetic factors influencing cardiovascular health.

Area of Science:

  • Cardiovascular Genetics
  • Lipid Metabolism
  • Molecular Epidemiology

Background:

  • Genetic polymorphisms in cholesteryl ester transfer protein (CETP) and lecithin-cholesterol acyltransferase (LCAT) may influence lipid profiles and cardiovascular disease risk.
  • High-density lipoprotein (HDL) size and subclass cholesterol levels are critical determinants of cardiovascular health.
  • Understanding the genetic underpinnings of HDL metabolism is crucial for assessing acute coronary syndrome (ACS) susceptibility.

Purpose of the Study:

  • To investigate the association between CETP and LCAT gene polymorphisms and ACS susceptibility.
  • To examine the impact of these polymorphisms on HDL size distribution and cholesterol levels within HDL subclasses.
  • To identify specific genetic variants that may contribute to the development of coronary atherosclerosis.

Main Methods:

  • Genotyping of CETP (rs4783961, rs708272) and LCAT (rs2292318) polymorphisms using 5' exonuclease TaqMan assays in 619 ACS patients and 607 controls.
  • Analysis of HDL subclasses and their cholesterol content in 100 healthy individuals using ultracentrifugation and native polyacrylamide gradient gel electrophoresis.
  • Statistical analysis including dominant models and linkage disequilibrium to assess associations with ACS risk and HDL parameters.

Main Results:

  • The G allele of CETP rs708272 polymorphism was significantly associated with an increased risk of ACS (OR = 1.45, pCDom = 0.036).
  • Linkage disequilibrium analysis identified a combination of polymorphisms associated with increased ACS risk (OR = 1.52, pC = 0.02).
  • CETP rs708272 G allele carriers exhibited lower cholesterol in HDL2a and HDL3a subclasses.
  • LCAT rs2292318 A allele carriers showed reduced overall HDL cholesterol (HDL-C) and cholesterol in all five HDL subclasses.

Conclusions:

  • The CETP rs708272 polymorphism is a significant risk factor for developing ACS.
  • Both CETP rs708272 and LCAT rs2292318 polymorphisms are associated with altered HDL-C levels and HDL subclass cholesterol content.
  • These genetic variations may play a role in the pathogenesis of coronary atherosclerosis and influence lipid metabolism.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
355
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
288
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
305
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
448
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.6K